Cargando…
复发性胸腺瘤的治疗
Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In th...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
中国肺癌杂志编辑部
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118328/ https://www.ncbi.nlm.nih.gov/pubmed/32102138 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.11 |
| _version_ | 1783514538894688256 |
|---|---|
| collection | PubMed |
| description | Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In this article, we review the previous literature and summarize the indications, efficacy and prognosis of different treatments for recurrent thymoma, so as to provide some reference for treatment criteria for recurrent thymoma. |
| format | Online Article Text |
| id | pubmed-7118328 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | 中国肺癌杂志编辑部 |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71183282020-04-07 复发性胸腺瘤的治疗 Zhongguo Fei Ai Za Zhi 综述 Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In this article, we review the previous literature and summarize the indications, efficacy and prognosis of different treatments for recurrent thymoma, so as to provide some reference for treatment criteria for recurrent thymoma. 中国肺癌杂志编辑部 2020-03-20 /pmc/articles/PMC7118328/ /pubmed/32102138 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.11 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/. |
| spellingShingle | 综述 复发性胸腺瘤的治疗 |
| title | 复发性胸腺瘤的治疗 |
| title_full | 复发性胸腺瘤的治疗 |
| title_fullStr | 复发性胸腺瘤的治疗 |
| title_full_unstemmed | 复发性胸腺瘤的治疗 |
| title_short | 复发性胸腺瘤的治疗 |
| title_sort | 复发性胸腺瘤的治疗 |
| topic | 综述 |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118328/ https://www.ncbi.nlm.nih.gov/pubmed/32102138 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.11 |
| work_keys_str_mv | AT fùfāxìngxiōngxiànliúdezhìliáo AT fùfāxìngxiōngxiànliúdezhìliáo AT fùfāxìngxiōngxiànliúdezhìliáo |